152 related articles for article (PubMed ID: 10408487)
1. Immunotherapy with Mycobacterium vaccae in patients with newly diagnosed pulmonary tuberculosis: a randomised controlled trial. Durban Immunotherapy Trial Group.
Lancet; 1999 Jul; 354(9173):116-9. PubMed ID: 10408487
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy with Mycobacterium vaccae as an addition to chemotherapy for the treatment of pulmonary tuberculosis under difficult conditions in Africa.
Onyebujoh PC; Abdulmumini T; Robinson S; Rook GA; Stanford JL
Respir Med; 1995 Mar; 89(3):199-207. PubMed ID: 7746913
[TBL] [Abstract][Full Text] [Related]
3. Mycobacterium vaccae (SRL172) immunotherapy as an adjunct to standard antituberculosis treatment in HIV-infected adults with pulmonary tuberculosis: a randomised placebo-controlled trial.
Mwinga A; Nunn A; Ngwira B; Chintu C; Warndorff D; Fine P; Darbyshire J; Zumla A;
Lancet; 2002 Oct; 360(9339):1050-5. PubMed ID: 12383985
[TBL] [Abstract][Full Text] [Related]
4. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
Bwire R; Borgdorff MW; Sticht-Groh V; Rieder HL; Kawuma HJ; Bretzel G; Rüsch-Gerdes S
East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516
[TBL] [Abstract][Full Text] [Related]
5. Randomized controlled trial of Mycobacterium vaccae immunotherapy in non-human immunodeficiency virus-infected ugandan adults with newly diagnosed pulmonary tuberculosis. The Uganda-Case Western Reserve University Research Collaboration.
Johnson JL; Kamya RM; Okwera A; Loughlin AM; Nyole S; Hom DL; Wallis RS; Hirsch CS; Wolski K; Foulds J; Mugerwa RD; Ellner JJ
J Infect Dis; 2000 Apr; 181(4):1304-12. PubMed ID: 10753731
[TBL] [Abstract][Full Text] [Related]
6. Double-blind placebo-controlled trial of Mycobacterium vaccae immunotherapy for tuberculosis in KwaZulu, South Africa, 1991-97.
Mayo RE; Stanford JL
Trans R Soc Trop Med Hyg; 2000; 94(5):563-8. PubMed ID: 11132390
[TBL] [Abstract][Full Text] [Related]
7. [The immunotherapeutic effect of Mycobacterium vaccae vaccine on initially treated pulmonary tuberculosis].
Luo Y;
Zhonghua Jie He He Hu Xi Za Zhi; 2001 Jan; 24(1):43-7. PubMed ID: 11802939
[TBL] [Abstract][Full Text] [Related]
8. Clarithromycin vs ciprofloxacin as adjuncts to rifampicin and ethambutol in treating opportunist mycobacterial lung diseases and an assessment of Mycobacterium vaccae immunotherapy.
Jenkins PA; Campbell IA; Banks J; Gelder CM; Prescott RJ; Smith AP
Thorax; 2008 Jul; 63(7):627-34. PubMed ID: 18250184
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of Mycobacterium vaccae immunotherapy for patients with tuberculosis: A systematic review and meta-analysis.
Huang CY; Hsieh WY
Hum Vaccin Immunother; 2017 Sep; 13(9):1960-1971. PubMed ID: 28604170
[TBL] [Abstract][Full Text] [Related]
10. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
API Consensus Expert Committee
J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapy of tuberculosis with Mycobacterium vaccae NCTC 11659.
Stanford JL; Stanford CA
Immunobiology; 1994 Oct; 191(4-5):555-63. PubMed ID: 7713570
[TBL] [Abstract][Full Text] [Related]
12. Immunological consequences of three doses of heat-killed Mycobacterium vaccae in the immunotherapy of tuberculosis.
Dlugovitzky D; Fiorenza G; Farroni M; Bogue C; Stanford C; Stanford J
Respir Med; 2006 Jun; 100(6):1079-87. PubMed ID: 16278080
[TBL] [Abstract][Full Text] [Related]
13. Does immunotherapy with heat-killed Mycobacterium vaccae offer hope for the treatment of multi-drug-resistant pulmonary tuberculosis?
Stanford JL; Stanford CA; Grange JM; Lan NN; Etemadi A
Respir Med; 2001 Jun; 95(6):444-7. PubMed ID: 11421500
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy with Mycobacterium vaccae in the treatment of tuberculosis.
Stanford J; Stanford C; Grange J
Front Biosci; 2004 May; 9():1701-19. PubMed ID: 14977580
[TBL] [Abstract][Full Text] [Related]
15. Immunological basis for the introduction of immunotherapy with Mycobacterium vaccae into the routine treatment of TB.
Dlugovitzky D; Stanford C; Stanford J
Immunotherapy; 2011 Apr; 3(4):557-68. PubMed ID: 21463195
[TBL] [Abstract][Full Text] [Related]
16. Effect of Mycobacterium vaccae (SRL172) immunotherapy on radiographic healing in tuberculosis.
Johnson JL; Nunn AJ; Fourie PB; Ormerod LP; Mugerwa RD; Mwinga A; Chintu C; Ngwira B; Onyebujoh P; Zumla A
Int J Tuberc Lung Dis; 2004 Nov; 8(11):1348-54. PubMed ID: 15581204
[TBL] [Abstract][Full Text] [Related]
17. Short-course chemotherapy in pulmonary tuberculosis. A controlled trial by the British Thoracic and Tuberculosis Association.
Lancet; 1975 Jan; 1(7899):119-24. PubMed ID: 46047
[TBL] [Abstract][Full Text] [Related]
18. [A clinical study on vaccine of Mycobacterium vaccae in treating pulmonary tuberculosis].
Wang W; Jin G; Ye Y; Xia X; Wang A; Zhuang Y; Li G; Sun H; Wang Z; Lin M; Chen H; Li J; Dan Z; Zhang X
Zhonghua Jie He He Hu Xi Za Zhi; 1999 Feb; 22(2):108-10. PubMed ID: 11820954
[TBL] [Abstract][Full Text] [Related]
19. Adjunctive vitamin D for treatment of active tuberculosis in India: a randomised, double-blind, placebo-controlled trial.
Daley P; Jagannathan V; John KR; Sarojini J; Latha A; Vieth R; Suzana S; Jeyaseelan L; Christopher DJ; Smieja M; Mathai D
Lancet Infect Dis; 2015 May; 15(5):528-34. PubMed ID: 25863562
[TBL] [Abstract][Full Text] [Related]
20. A pilot study of antituberculosis combinations comparing rifabutin with rifampicin in the treatment of HIV-1 associated tuberculosis. A single-blind randomized evaluation in Ugandan patients with HIV-1 infection and pulmonary tuberculosis.
Schwander S; Rüsch-Gerdes S; Mateega A; Lutalo T; Tugume S; Kityo C; Rubaramira R; Mugyenyi P; Okwera A; Mugerwa R
Tuber Lung Dis; 1995 Jun; 76(3):210-8. PubMed ID: 7548903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
